Cancer biomarkers

In cancer research and medicine, biomarkers are used in three primary ways:

  • To help diagnose conditions, as in the case of identifying early stage cancers (Diagnostic)
  • To forecast how aggressive a condition is, as in the case of determining a patient's ability to fare in the absence of treatment (Prognostic)
  • To predict how well a patient will respond to treatment (Predictive)

  • Role of biomarkers in cancer research and medicine
  • Uses of biomarkers in cancer research
  • Types of cancer biomarkers
  • Intra tumor-phenotypic heterogeneity
  • Intra tumor-clonal heterogeneity
  • Clinical and intelluctual advances

Related Conference of Cancer biomarkers

September 13-14, 2018

11th Annual Congress on Immunology & Immunotechnology

Zurich, Switzerland
September 17-18, 2018

3rd International Conference on Tumor & Cancer Immunology and Immunotherapy

San Diego, California, USA
September 17-18, 2018

3rd International Conference on Tumor & Cancer Immunology and Immunotherapy

San Diego, California, USA
September 20-21, 2018

Global Meet on Immunology and Molecular Biology

Oslo, Norway
October 19-20, 2018

10th World Congress and Expo on Immunology

New York, USA
October 29-30, 2018

6th International Conference on HIV/AIDS, STDs and STIs

San Francisco, USA
November 22-23, 2018

World Conference on Vaccine and Immunology

Bucharest, Romania
November 26-27, 2018

3rd International Conference on Autoimmunity

Dublin, Ireland
December 06-08, 2018

Annual Congress and Expo on Antibiotics

Amsterdam, Netherlands
March 04-05, 2019

10th Molecular Immunology & Immunogenetics Congress

Barcelona, Spain
March 18-19, 2019

11th Global Summit on Immunology and Cell Biology

Sydney, Australia
June 13-14, 2019 |

10th European Immunology Conference

Berlin, Germany

Cancer biomarkers Conference Speakers

Recommended Sessions

Related Journals

Are you interested in